- UroToday Home
- Recent Abstracts
- Urologic Oncology
Investigative Urology
Targeting p53 in vivo: A first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer - Abstract
November 29, 2012
Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile - Abstract
November 29, 2012
A multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenance - Abstract
November 29, 2012
Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer - Abstract
November 29, 2012
Suppression of cancer progression by MGAT1 shRNA knockdown - Abstract
November 29, 2012
NAD(P)H:quinone oxidoreductase 1 protects bladder epithelium against painful bladder syndrome in mice - Abstract
November 29, 2012
Elevated steady-state bladder preload activates myosin phosphorylation: Detrusor smooth muscle is a preload tension sensor - Abstract
November 29, 2012
Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma - Abstract
November 28, 2012
Oncolytic viruses in the treatment of bladder cancer - Abstract
November 28, 2012
Metadherin is a novel prognostic marker for bladder cancer progression and overall patient survival - Abstract
November 28, 2012
Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells - Abstract
November 28, 2012
HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma - Abstract
November 28, 2012